GLP-1 weight-loss drugs are reshaping obesity and diabetes care in India—promising major metabolic benefits, but raising questions over access, side effects and long-term safety
Gene editing is rewriting the future of medicine, as seen in the case of a baby named KJ Muldoon who got a fully personalised therapy for a fatal genetic disorder